✦ LIBER ✦

Adoptive immunotherapy with lymphokine activated killer cells in HIV positive patients

✍ Scribed by A.J.A. Sultan; J.C. Sharp

Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 53 KB
Volume: 10
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(88)90252-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adoptive immunotherapy with lymphokine-a

Adoptive immunotherapy with lymphokine-activated killer cells plus recombinant interleukin 2 in patients with unresectable hepatocellular carcinoma

✍ Saburo Onishi; Toshiji Saibara; Masanao Fujikawa; Hiroshi Sakaeda; Yasushi Matsu 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

Ten patients with hepatocellular carcinoma, three of whom had pulmonary metastasis, were treated with adoptive immunotherapy using autologous lymphokineactivated killer cells plus recombinant interleukin 2. Patients received 16 pg per day of recombinant interleukin 2 consecutively (for 14 to 64 days

Immunotherapy of cancer with lymphokines

Immunotherapy of cancer with lymphokines and lymphokine-activated killer cells

✍ John W. Yarbro 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 996 KB

Our expanding knowledge of the immune system has provided a basis of rationality for immunotherapy . Some non-specific immunotherapy has achieved the status of standard treatment: interferon in hairy cell leukemia and chronic myelogenous leukemia, BCG in bladder cancer, and levamisole in colon cance

Histological evidence of natural killer

Histological evidence of natural killer cell aggregation against malignant melanoma induced by adoptive immunotherapy with lymphokine-activated killer cells

✍ T. Yamamura; Y. Fujitani; T. Kawauchi; E. Wada; Y. Kobayashi; K. Yoshikawa; H. O 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Adoptive immunotherapy for recurrent gli

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2

✍ Randall E. Merchant; Angus J. Grant; Lynn H. Merchant; Harold F. Young 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Thirteen patients with recurrent glioblastoma were treated with adoptively transferred autologous lymphokine activated killer (LAK) cells and recombinant interleukin-2 (rIL-2). Patients' blood mononuclear cells (MNC) obtained by leukapheresis were cultured at 2.5 million MNC per ml for 3 to 5 days i

Adoptive immunotherapy for unresectable

Adoptive immunotherapy for unresectable or recurrent pancreatic cancer, using lymphokine-activated killer cells or cytotoxic T cells

✍ Oka, Masaaki ;Suzuki, Michinari ;Hazama, Shoichi ;Suzuki, Takashi 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 513 KB

Lymphokine-activated killer cell and nat

Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis

✍ Thomas V. Kantor; Theresa L. Whiteside; Diana Friberg; Robert B. Buckingham; Tho 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Objective. To determine the ability of T lymphocytes and natural killer (NK) cells from patients with systemic sclerosis (SSc) to respond to cytokines and to generate immune effector cells. Methods. The numbers and percentages of peripheral blood T and NK cells were examined by 2-color flow cytometr